大葉大學圖書館 |

Defects in T cell trafficking and resistance to cancer immunotherapy[electronic resource] /

紀錄類型:	書目-電子資源 : Monograph/item
杜威分類號:	616.99406
書名/作者:	Defects in T cell trafficking and resistance to cancer immunotherapy/ edited by Emmanuel Donnadieu.
其他作者:	Donnadieu, Emmanuel.
出版者:	Cham : : Springer International Publishing :, 2016.
面頁冊數:	viii, 199 p. : : ill., digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Cancer - Immunotherapy.
標題:	T cells - Therapeutic use.
標題:	Drug resistance in cancer cells.
標題:	Biomedicine.
標題:	Cancer Research.
標題:	Immunology.
標題:	Molecular Medicine.
ISBN:	9783319422237
ISBN:	9783319422213
內容註:	Introduction -- Basic rules of T cell migration -- Regulation of anti-tumor T cell migration and function: contribution of real-time imaging -- Vascular normalization, T cell trafficking and anti-tumor immunity -- Disruption of anti-tumor T cell responses by cancer-associated fibroblasts -- Cancer-associated Tertiary Lymphoid Structures, from basic knowledge toward therapeutic target in clinic -- Homing Improvement: Boosting T Cell Trafficking for Cancer Immunotherapy -- Chemokines and T cell trafficking into tumors. Strategies to enhance recruitment of T cells into tumors -- Strategies to enhance migration and persistence of chimeric antigen receptor (CAR)-T cells into tumors.
摘要、提要註:	This volume focuses on recent advances in understanding T cells as key players in antitumor immune responses, and as a result T cell-based immunotherapy is starting to transform the treatment of advanced cancers. However, despite recent successes, many patients with cancer fail to respond to these treatments. Defective migration of T cells into and within tumors is considered as an important resistance mechanism to cancer immunotherapy. The volume includes three sections. The first section covers general knowledge about T cell trafficking during a normal immune response but also during tumor development. The second section provides an in-depth description of the different obstacles that prevent T cells from migrating and contacting tumor cells. The third section explores therapeutic strategies to improve trafficking of T cells into tumors and, thus, to enhance the effectiveness of cancer immunotherapy.
電子資源:	http://dx.doi.org/10.1007/978-3-319-42223-7

Defects in T cell trafficking and resistance to cancer immunotherapy[electronic resource] /
Defects in T cell trafficking and resistance to cancer immunotherapy[electronic resource] /edited by Emmanuel Donnadieu. - Cham :Springer International Publishing :2016. - viii, 199 p. :ill., digital ;24 cm. - Resistance to targeted anti-cancer therapeutics,2196-5501. - Resistance to targeted anti-cancer therapeutics..

Introduction -- Basic rules of T cell migration -- Regulation of anti-tumor T cell migration and function: contribution of real-time imaging -- Vascular normalization, T cell trafficking and anti-tumor immunity -- Disruption of anti-tumor T cell responses by cancer-associated fibroblasts -- Cancer-associated Tertiary Lymphoid Structures, from basic knowledge toward therapeutic target in clinic -- Homing Improvement: Boosting T Cell Trafficking for Cancer Immunotherapy -- Chemokines and T cell trafficking into tumors. Strategies to enhance recruitment of T cells into tumors -- Strategies to enhance migration and persistence of chimeric antigen receptor (CAR)-T cells into tumors.

This volume focuses on recent advances in understanding T cells as key players in antitumor immune responses, and as a result T cell-based immunotherapy is starting to transform the treatment of advanced cancers. However, despite recent successes, many patients with cancer fail to respond to these treatments. Defective migration of T cells into and within tumors is considered as an important resistance mechanism to cancer immunotherapy. The volume includes three sections. The first section covers general knowledge about T cell trafficking during a normal immune response but also during tumor development. The second section provides an in-depth description of the different obstacles that prevent T cells from migrating and contacting tumor cells. The third section explores therapeutic strategies to improve trafficking of T cells into tumors and, thus, to enhance the effectiveness of cancer immunotherapy.

ISBN: 9783319422237

Standard No.: 10.1007/978-3-319-42223-7doiSubjects--Topical Terms:

406740
Cancer
--Immunotherapy.

LC Class. No.: RC271.I45

Dewey Class. No.: 616.99406

Defects in T cell trafficking and resistance to cancer immunotherapy[electronic resource] /
LDR:02647nmm a2200325 a 4500 001 465376
003 DE-He213
005 20160830165628.0
006 m d
007 cr nn 008maaau
008 170411s2016 gw s 0 eng d
020 $a 9783319422237 $q (electronic bk.)
020 $a 9783319422213 $q (paper)
024 7 $a 10.1007/978-3-319-42223-7 $2 doi
035 $a 978-3-319-42223-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RC271.I45
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.99406 $2 23
090 $a RC271.I45 $b D313 2016
245 0 0 $a Defects in T cell trafficking and resistance to cancer immunotherapy $h [electronic resource] / $c edited by Emmanuel Donnadieu.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a viii, 199 p. : $b ill., digital ; $c 24 cm.
490 1 $a Resistance to targeted anti-cancer therapeutics, $x 2196-5501
505 0 $a Introduction -- Basic rules of T cell migration -- Regulation of anti-tumor T cell migration and function: contribution of real-time imaging -- Vascular normalization, T cell trafficking and anti-tumor immunity -- Disruption of anti-tumor T cell responses by cancer-associated fibroblasts -- Cancer-associated Tertiary Lymphoid Structures, from basic knowledge toward therapeutic target in clinic -- Homing Improvement: Boosting T Cell Trafficking for Cancer Immunotherapy -- Chemokines and T cell trafficking into tumors. Strategies to enhance recruitment of T cells into tumors -- Strategies to enhance migration and persistence of chimeric antigen receptor (CAR)-T cells into tumors.
520 $a This volume focuses on recent advances in understanding T cells as key players in antitumor immune responses, and as a result T cell-based immunotherapy is starting to transform the treatment of advanced cancers. However, despite recent successes, many patients with cancer fail to respond to these treatments. Defective migration of T cells into and within tumors is considered as an important resistance mechanism to cancer immunotherapy. The volume includes three sections. The first section covers general knowledge about T cell trafficking during a normal immune response but also during tumor development. The second section provides an in-depth description of the different obstacles that prevent T cells from migrating and contacting tumor cells. The third section explores therapeutic strategies to improve trafficking of T cells into tumors and, thus, to enhance the effectiveness of cancer immunotherapy.
650 0 $a Cancer $x Immunotherapy. $3 406740
650 0 $a T cells $x Therapeutic use. $3 669384
650 0 $a Drug resistance in cancer cells. $3 603048
650 1 4 $a Biomedicine. $3 463454
650 2 4 $a Cancer Research. $3 463530
650 2 4 $a Immunology. $3 402223
650 2 4 $a Molecular Medicine. $3 463625
700 1 $a Donnadieu, Emmanuel. $3 669382
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
830 0 $a Resistance to targeted anti-cancer therapeutics. $3 669383
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-42223-7
950 $a Biomedical and Life Sciences (Springer-11642)